United Kingdom
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 419.36 M
|
March 31, 2024 | USD 11.13 | -2.11% |
|
United Kingdom |
|
2 |
USD 250.03 M
|
Dec. 31, 2023 | USD 13.39 | 4.86% |
|
United Kingdom |
|
3 |
USD 173.83 M
|
Dec. 31, 2023 | USD 4.31 | 3.36% |
|
United Kingdom |
|
4 |
USD 120.76 M
|
Sept. 30, 2024 | USD 56.22 | -0.33% |
|
United Kingdom |
|
5 |
USD 92.87 M
|
Dec. 31, 2023 | USD 57.30 | 0.10% |
|
United Kingdom |
|
6 |
USD 63.18 M
|
Dec. 31, 2023 | USD 0.03 | -3.20% |
|
United Kingdom |
|
7 |
USD 39.78 M
|
June 30, 2024 | USD 0.07 | -16.83% |
|
United Kingdom |
|
8 |
USD 37.92 M
|
Dec. 31, 2023 | USD 0.23 | 1.77% |
|
United Kingdom |
|
9 |
USD 34.35 M
|
Dec. 31, 2023 | USD 32.88 | 0.83% |
|
United Kingdom |
|
10 |
USD 32.01 M
|
Dec. 31, 2023 | USD 5.33 | 1.52% |
|
United Kingdom |
|
11 |
USD 21.48 M
|
Dec. 31, 2023 | USD 49.95 | -1.36% |
|
United Kingdom |
|
12 |
USD 21.12 M
|
Dec. 31, 2023 | USD 16.92 | 0.06% |
|
United Kingdom |
|
13 |
USD 12.98 M
|
April 30, 2024 | USD 0.12 | -0.69% |
|
United Kingdom |
|
14 |
USD 11.94 M
|
Dec. 31, 2023 | USD 1.98 | 0.38% |
|
United Kingdom |
|
15 |
USD 8.17 M
|
Dec. 31, 2023 | USD 14.61 | -1.71% |
|
United Kingdom |
|
16 |
USD 8.05 M
|
June 30, 2024 | USD 0.03 | 1.77% |
|
United Kingdom |
|
17 |
USD 7.97 M
|
Dec. 31, 2023 | USD 3.01 | 2.73% |
|
United Kingdom |
|
18 |
USD 7.02 M
|
Dec. 31, 2023 | USD 1.09 | -19.26% |
|
United Kingdom |
|
19 |
USD 6.21 M
|
March 31, 2024 | USD 1.06 | -3.64% |
|
United Kingdom |
|
20 |
USD 5.79 M
|
Dec. 31, 2023 | USD 0.20 | -2.58% |
|
United Kingdom |
|
21 |
USD 5.71 M
|
June 30, 2024 | USD 0.22 | 1.80% |
|
United Kingdom |
|
22 |
USD 5.66 M
|
Dec. 31, 2023 | USD 4.20 | -6.92% |
|
United Kingdom |
|
23 |
USD 5.54 M
|
June 30, 2024 | USD 0.25 | 0.38% |
|
United Kingdom |
|
24 |
USD 4.09 M
|
Dec. 31, 2023 | USD 1.16 | -5.69% |
|
United Kingdom |
|
25 |
USD 3.67 M
|
Dec. 31, 2023 | USD 0.57 | 0.38% |
|
United Kingdom |
|
26 |
USD 3.50 M
|
March 31, 2024 | USD 0.09 | -2.82% |
|
United Kingdom |
|
27 |
USD 3.19 M
|
Dec. 31, 2023 | USD 0.21 | 3.52% |
|
United Kingdom |
|
28 |
USD 1.65 M
|
March 31, 2024 | USD 1.69 | NA |
|
United Kingdom |
|
29 |
USD 427.59 K
|
June 30, 2024 | USD 0.01 | -9.39% |
|
United Kingdom |
|
30 |
USD 0.00
|
Dec. 31, 2023 | USD 0.03 | -12.38% |
|
United Kingdom |
|
31 |
USD 0.00
|
May 31, 2024 | USD 0.24 | 1.95% |
|
United Kingdom |
|
32 |
USD 0.00
|
Dec. 31, 2023 | USD 0.03 | 4.40% |
|
United Kingdom |
|
33 |
USD -73.80
|
Dec. 31, 2023 | USD 0.04 | -11.51% |
|
United Kingdom |
|
34 |
USD -27.00 K
|
Dec. 31, 2023 | USD 0.05 | 0.38% |
|
United Kingdom |
|
35 |
USD -119.60 K
|
Dec. 31, 2023 | USD 0.05 | 1.59% |
|
United Kingdom |
|
36 |
USD -179.21 K
|
Sept. 30, 2024 | USD 0.16 | 4.56% |
|
United Kingdom |
|
37 |
USD -229.02 K
|
Dec. 31, 2023 | USD 0.70 | -3.05% |
|
United Kingdom |
|
38 |
USD -300.27 K
|
Dec. 31, 2023 | USD 0.16 | 0.38% |
|
United Kingdom |
|
39 |
USD -883.00 K
|
Dec. 31, 2023 | USD 2.21 | 0.46% |
|
United Kingdom |
|
40 |
USD -1.43 M
|
Dec. 31, 2023 | USD 0.20 | -0.86% |
|
United Kingdom |
|
41 |
USD -1.65 M
|
Dec. 31, 2023 | USD 0.59 | 0.38% |
|
United Kingdom |
|
42 |
USD -1.91 M
|
March 31, 2024 | USD 0.09 | -6.74% |
|
United Kingdom |
|
43 |
USD -2.69 M
|
April 30, 2024 | USD 0.65 | -1.49% |
|
United Kingdom |
|
44 |
USD -3.82 M
|
Aug. 31, 2023 | USD 0.13 | 4.36% |
|
United Kingdom |
|
45 |
USD -4.48 M
|
Dec. 31, 2023 | USD 0.24 | -0.40% |
|
United Kingdom |
|
46 |
USD -4.64 M
|
Dec. 31, 2023 | USD 0.32 | 2.99% |
|
United Kingdom |
|
47 |
USD -4.66 M
|
March 31, 2024 | USD 0.80 | 0.38% |
|
United Kingdom |
|
48 |
USD -5.71 M
|
Dec. 31, 2023 | USD 1.42 | -3.02% |
|
United Kingdom |
|
49 |
USD -10.44 M
|
June 30, 2024 | USD 38.56 | 0.38% |
|
United Kingdom |
|
50 |
USD -16.16 M
|
Dec. 31, 2023 | USD 5.04 | -2.51% |
|
United Kingdom |
The Healthcare company in United Kingdom with the highest Net Cash Used Provided By Financing Activities is Roivant Sciences Ltd. (NasdaqGS: ROIV) at USD 419.36 M.
The Healthcare company in United Kingdom with the lowest Net Cash Used Provided By Financing Activities is GSK plc (LSE: GSK.L) at USD -7.18 B.
The top 10 Healthcare companies in United Kingdom by Net Cash Used Provided By Financing Activities are Roivant Sciences Ltd., Bicycle Therapeutics plc, COMPASS Pathways plc, Diploma PLC, Verona Pharma plc, Shield Therapeutics plc, Allergy Therapeutics plc, Creo Medical Limited, Immunocore Holdings plc and Silence Therapeutics plc.
The bottom 10 Healthcare companies in United Kingdom by Net Cash Used Provided By Financing Activities are GSK plc, AstraZeneca PLC, Haleon plc, Smiths Group plc, Hikma Pharmaceuticals PLC, Smith & Nephew plc, Halma plc, ConvaTec Group Plc, Spire Healthcare Group plc and Alliance Pharma plc.